VIA
NGM

Vident Investment Advisory’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Vident Investment Advisory’s Portfolio NGM Stock Details NGM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-48,046
Closed -$628K – 1364
2022
Q3 		$628K Sell
48,046
-5,148
-10% -$67.3K 0.02% 719
2022
Q2 		$682K Buy
+53,194
New +$682K 0.02% 757